🎓 Capstone Project · Global Healthcare Leaders Program · Harvard Medical School
Value-Based Pathway in Surgical Oncology

Global Oncology Bridge Connecting U.S. Insurers with World-Class Oncology Care

Global Oncology Bridge enables selected U.S. insurer members to undergo surgical oncology procedures in Greece — at 30–50% lower total cost, without compromising quality or continuity of care.

Request a Partnership Call Explore the Model
30–50%
Cost Reduction Per Episode
JCI
Accredited Partner Hospital
2006
Robotic Surgery Since
Zero
Care Fragmentation
Who We Are

A New Bridge Between U.S. Insurers and Global Surgical Excellence

"Global Oncology Bridge is a U.S.-based entity designed to connect health insurers with world-class oncology surgery abroad — at dramatically lower cost, without ever compromising clinical quality or care continuity."

Global Oncology Bridge LLC is the operational backbone of the Value-Based Pathway. We coordinate, contract, and navigate every aspect of the patient journey — from insurer engagement to post-surgical handoff back to U.S. providers.

Our partner institution is Athens Medical Center (AMC) — a JCI-accredited hospital and international training center for robotic and minimally invasive oncology, operating Da Vinci robotic surgery since 2006.

Global Oncology Bridge was developed as a capstone project within the Global Healthcare Leaders Program at Harvard Medical School — grounded in evidence, strategic leadership, and health system innovation.

🏛️

U.S.-Based LLC

Global Oncology Bridge LLC handles all contracting, compliance, and insurer coordination from within the United States.

🤝

Athens Medical Center Partnership

JCI-accredited, internationally recognized — AMC holds U.S.-equivalent clinical standards with deep expertise in robotic oncology.

🎯

Focused Surgical Scope

High-cost elective oncologic procedures: colorectal, thoracic, and urologic — for carefully selected, clinically appropriate patients.

🎓

Harvard Medical School Capstone

Developed within the Global Healthcare Leaders Program at Harvard Medical School — one of the world's most prestigious executive healthcare programs.

The Global Oncology Bridge Model

A Closed-Loop Value-Based Pathway Engineered for Outcomes

From pre-operative consultation to post-surgical handoff — every step is structured, supervised, and seamlessly coordinated.

01

Pre-Operative Teleconsultation

Patient and family meet with AMC specialists and U.S. oncologists via teleconsult. Full clinical review and multidisciplinary tumor board involvement.

02

Dedicated Oncology Liaison

A single point of coordination throughout the entire pathway — managing travel, accommodation, communication, and clinical scheduling.

03

Robotic & Minimally Invasive Surgery

Performed at Athens Medical Center using Da Vinci robotic systems by surgeons with U.S. training and international recognition.

04

Bundled Fixed Pricing

One transparent price covering procedure, hospital stay, travel, and accommodation. No surprise billing. Full cost predictability for insurers.

05

Structured Post-Surgical Handoff

Comprehensive documentation and direct handoff back to the patient's U.S. oncology team — ensuring zero fragmentation in ongoing care.

06

JCI-Equivalent Clinical Standards

Every protocol mirrors U.S. accreditation requirements. AMC is an international training center for advanced oncologic procedures.

Dr. Vassilis Ramfidis

Dr. Vassilis Ramfidis, MD, MS

Founder · Global Oncology Bridge LLC
General Director, Faros Cancer Institute · Athens Medical Center
Head of Oncology · 251 Hellenic Air Force General Hospital
Scientific Director · Early Drug Development Unit, AMC
President & Founder · VIRTUS Center for Medical Research
🎓

Global Healthcare Leaders Program
Harvard Medical School · Selected 2025

Medical Oncology Clinical Leadership Value-Based Care Health Policy Rare Cancers
Our Team

Meet the Founder

Dr. Vassilis Ramfidis is a medical oncologist and healthcare leader with a distinguished career spanning clinical oncology, translational research, health policy, and international collaboration. He currently serves as General Director of the Faros Cancer Institute at Athens Medical Center and Head of Oncology at the 251 Hellenic Air Force General Hospital.

Trained at world-class institutions including Dana-Farber Cancer Institute (Boston), the University of Pittsburgh Cancer Institute, the Royal Marsden Hospital (London), and Centre Léon Bérard (Lyon), he brings exceptional international clinical perspective to health system design.

In September 2025, he was selected to the Global Healthcare Leaders Program at Harvard Medical School. Global Oncology Bridge is the capstone project of that program.

Leadership & Executive Roles

2021–Present
General Director — Faros Cancer Institute, Athens Medical Center

Oversees strategy and operations for a private cancer center focused on precision oncology. Leads clinical innovation and institutional partnerships.

2021–Present
Head of Oncology — 251 Hellenic Air Force General Hospital

Directs clinical oncology services. Implements modern treatment pathways and multidisciplinary cancer boards.

2025–Present
Scientific Director — Early Drug Development Unit, Athens Medical Center

In collaboration with PPD, part of Thermo Fisher Scientific U.S. Member of the Early Phase Oncology Specialized Site Network (EDOS).

2022–Present
Founder & President — VIRTUS Center for Medical Research (NGO)

Nonprofit advancing oncology research, rare cancer advocacy, and public health education — expanding to the United States.

2019–Present
Health Policy Advisor — Ministry of Health, Greece

Scientific lead for the national Breast Cancer Screening Program "Fofi Genimata." Member, National Public Health Expert Committee.

2025–Present
Health Care Leadership Lecturer — School of Public Health, University of West Attica

Teaches postgraduate students in clinical leadership and mentorship.

Education & International Training

2025–Present
Global Healthcare Leaders Program — Harvard Medical School

Selected participant. Global Oncology Bridge is the capstone project of this executive program.

2025
MS in Leadership & Innovation in Health Care

National School of Public Health, University of West Attica, Greece.

2018
Subspecialty Training — Dana-Farber Cancer Institute, Boston, USA
2018
Subspecialty Training — Royal Marsden Hospital, London, UK
2019
Subspecialty Training — Centre Léon Bérard, Lyon, France
2013
Research Fellowship — University of Pittsburgh Cancer Institute, USA
2011
MS in Thoracic Oncology — NKUA, Greece

Awarded full academic scholarship.

2006
MD — Aristotle University of Thessaloniki, Greece

📎 Full CV available upon request via the contact form below.

Get In Touch

Partner With Global Oncology Bridge

Whether you represent a health insurer, employer group, or oncology practice — we'd welcome a conversation about how Global Oncology Bridge can deliver value for your members and patients.

🏢
Entity

Global Oncology Bridge LLC — United States

👤
Founder & Director

Dr. Vassilis Ramfidis, MD, MS

✉️
📞
🔗
🌐
Partner Institution

Athens Medical Center — JCI Accredited, Greece

🔒 Your information is confidential and used solely to respond to your inquiry.